Description
Sodium-glucose cotransporter 2 (SGLT2), expressed in the proximal renal tubules, is responsible for the majority of the reabsorption of filtered glucose from the tubular lumen. Dapagliflozin is an inhibitor of SGLT2. By inhibiting SGLT2, dapagliflozin reduces reabsorption of filtered glucose and lowers the renal threshold for glucose, and thereby increases urinary glucose excretion.
Additional information
| brand | Pharmevo (Private) |
|---|
Related products
-
+ wishlist
Empaphage L 5mg+25mg
Original price was: ₨600.00.₨580.00Current price is: ₨580.00.Add to cart
